Bernhard Benka

Follow

Generating author description...

Common Coauthors
Commonly Cited References
Action Title Year Authors # of times referenced
+ PDF Chat Impact of influenza vaccination programmes among the elderly population on primary care, Portugal, Spain and the Netherlands: 2015/16 to 2017/18 influenza seasons 2019 Ausenda Machado
Clara Mazagatos
Frederika Dijkstra
Irina Kislaya
Alin Gherasim
Scott McDonald
Esther Kissling
Marta Valenciano
Adam Meijer
M. Hooiveld
1
+ PDF Chat Estimating the burden of SARS-CoV-2 in France 2020 Henrik Salje
CĂ©cile Tran Kiem
Noémie Lefrancq
Noémie Courtejoie
Paolo Bosetti
Juliette Paireau
Alessio Andronico
Nathanaël Hozé
Jehanne Richet
Claire-Lise Dubost
1
+ PDF Chat Estimation of SARS-CoV-2 mortality during the early stages of an epidemic: A modeling study in Hubei, China, and six regions in Europe 2020 Anthony Hauser
Michel Jacques Counotte
Charles C. Margossian
Garyfallos Konstantinoudis
Nicola Low
Christian L. Althaus
Julien Riou
1
+ PDF Chat Substantial underestimation of SARS-CoV-2 infection in the United States 2020 Sean L. Wu
Andrew Mertens
Yoshika S. Crider
Anna Nguyen
Nolan N. Pokpongkiat
Stephanie Djajadi
Anmol Seth
Michelle S. Hsiang
John M. Colford
Art Reingold
1
+ Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in Asia Pacific and Europe 2020 Emeline Han
Melisa Mei Jin Tan
Eva Turk
Devi Sridhar
GM Leung
Kenji Shibuya
Nima Asgari‐Jirhandeh
Juhwan Oh
Alberto L. García‐Basteiro
Johanna Hanefeld
1
+ Global perspective of COVID‐19 epidemiology for a full‐cycle pandemic 2020 John P. A. Ioannidis
1
+ Infection fatality rate of COVID-19 inferred from seroprevalence data 2020 John P. A. Ioannidis
1
+ SARS‐CoV‐2 re‐infection risk in Austria 2021 Stefan Pilz
Ali Chakeri
John P. A. Ioannidis
Lukas Richter
Verena Theiler‐Schwetz
Christian Trummer
Robert Krause
Franz Allerberger
1
+ Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study 2021 Jamie Lopez Bernal
Nick Andrews
Charlotte Gower
Chris Robertson
Julia Stowe
Elise Tessier
Ruth Simmons
Simon Cottrell
Richard J. Roberts
Mark G. O’Doherty
1
+ PDF Chat Estimating effective infection fatality rates during the course of the COVID-19 pandemic in Germany 2021 Christian Staerk
Tobias Wistuba
Andreas Mayr
1
+ Over- and under-estimation of COVID-19 deaths 2021 John P. A. Ioannidis
1
+ The age-standardized incidence, mortality, and case fatality rates of COVID-19 in 79 countries: a cross-sectional comparison and their correlations with associated factors 2021 Dongui Hong
Sohyae Lee
Yoon‐Jung Choi
Sungji Moon
Yoonyoung Jang
Yoon-Min Cho
Hyojung Lee
Sukhong Min
Hyeree Park
Seokyung Hahn
1
+ Estimated number of deaths directly averted in people 60 years and older as a result of COVID-19 vaccination in the WHO European Region, December 2020 to November 2021 2021 Margaux M. I. Meslé
Jeremy Brown
Piers Mook
José E. Hagan
Roberta Pastore
Nick Bundle
Gianfranco Spiteri
Giovanni Ravasi
Nathalie Nicolay
Nick Andrews
1
+ PDF Chat Variation in the COVID-19 infection–fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis 2022 1
+ The end of the COVID‐19 pandemic 2022 John P. A. Ioannidis
1
+ PDF Chat Seroprevalence, Waning and Correlates of Anti-SARS-CoV-2 IgG Antibodies in Tyrol, Austria: Large-Scale Study of 35,193 Blood Donors Conducted between June 2020 and September 2021 2022 Anita Siller
Lisa Seekircher
Gregor A. Wachter
Manfred Astl
Lena Tschiderer
Bernhard Pfeifer
Manfred Gaber
Harald Schennach
Peter Willeit
1
+ Global impact of the first year of COVID-19 vaccination: a mathematical modelling study 2022 Oliver J. Watson
Gregory Barnsley
Jaspreet Toor
Alexandra B. Hogan
Peter Winskill
Azra C. Ghani
1
+ PDF Chat Estimating deaths averted and cost per life saved by scaling up mRNA COVID-19 vaccination in low-income and lower-middle-income countries in the COVID-19 Omicron variant era: a modelling study 2022 Alexandra Savinkina
Alyssa Bilinski
Meagan C. Fitzpatrick
A. David Paltiel
Zain Rizvi
Joshua A. Salomon
Thomas Thornhill
Gregg Gonsalves
1
+ PDF Chat Duration of immune protection of SARS-CoV-2 natural infection against reinfection 2022 Hiam Chemaitelly
Nico Nagelkerke
Houssein H. Ayoub
Peter Coyle
Patrick Tang
Hadi M. Yassine
Hebah A. Al-Khatib
Maria K. Smatti
Mohammad R. Hasan
Zaina Al Kanaani
1
+ PDF Chat Novel methods for estimating the instantaneous and overall COVID-19 case fatality risk among care home residents in England 2022 Christopher E. Overton
Luke Webb
Uma Datta
Mike Fursman
Jo Hardstaff
Iina Hiironen
Karthik Paranthaman
Heather Riley
James Sedgwick
Julia Verne
1
+ Age-stratified infection fatality rate of COVID-19 in the non-elderly population 2022 Angelo Maria Pezzullo
Cathrine Axfors
Despina G. Contopoulos‐Ioannidis
Alexandre Apostolatos
John P. A. Ioannidis
1
+ Expert review of global real-world data on COVID-19 vaccine booster effectiveness and safety during the omicron-dominant phase of the pandemic 2022 Rontgene Solante
Carlos Álvarez
Erlina Burhan
Suwat Chariyalertsak
Nan‐Chang Chiu
Sunate Chuenkitmongkol
Do Van Dung
Kao‐Pin Hwang
Javier Ortiz Ibarra
Sasisopin Kiertiburanakul
1
+ PDF Chat Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies 2022 Isabel Bergeri
Mairead Whelan
Harriet Ware
Lorenzo Subissi
Anthony Nardone
Hannah C. Lewis
Zihan Li
Xiaomeng Ma
Marta Valenciano
Brianna Cheng
1
+ Estimated global public health and economic impact of COVID-19 vaccines in the pre-omicron era using real-world empirical data 2022 Jingyan Yang
Shailja Vaghela
Benjamin Yarnoff
SolĂšne de Boisvilliers
Manuela Di Fusco
Timothy L. Wiemken
Moe H. Kyaw
John M. McLaughlin
Jennifer L. Nguyen
1
+ PDF Chat COVID-19 mortality attenuated during widespread Omicron transmission, Denmark, 2020 to 2022 2023 Nikolaj Ulrik Friis
Tomas Martin-Bertelsen
Rasmus Kristoffer Pedersen
Jens Nielsen
Tyra Grove Krause
Viggo Andreasen
Lasse S Vestergaard
1
+ PDF Chat High variability of COVID-19 case fatality rate in Germany 2023 Matthias Wjst
Clemens‐Martin Wendtner
1
+ PDF Chat Assessing the impacts of COVID-19 vaccination programme’s timing and speed on health benefits, cost-effectiveness, and relative affordability in 27 African countries 2023 Yang Liu
Simon R. Procter
Carl A. B. Pearson
Andrés Madriz Montero
Sergio Torres‐Rueda
Elias Asfaw
Benjamin Uzochukwu
Tom Drake
Eleanor Bergren
Rosalind M. Eggo
1
+ PDF Chat Dynamics of SARS-CoV-2 infection hospitalisation and infection fatality ratios over 23 months in England 2023 Oliver Eales
David Haw
Haowei Wang
Christina Atchison
Deborah Ashby
Graham Cooke
William Barclay
Helen Ward
Ara Darzi
Christl A. Donnelly
1
+ PDF Chat Estimating SARS‐CoV‐2 infections and associated changes in COVID‐19 severity and fatality 2023 Valentina Marziano
Giorgio Guzzetta
Francesco Menegale
Chiara Sacco
Daniele Petrone
Alberto Mateo‐Urdiales
Martina Del Manso
Antonino Bella
Massimo Fabiani
Maria Fenicia Vescio
1
+ Effectiveness of social distancing measures and lockdowns for reducing transmission of COVID-19 in non-healthcare, community-based settings 2023 Caitriona Murphy
Wey Wen Lim
Cathal Mills
Jessica Y. Wong
Dongxuan Chen
Yanmy Xie
Mingwei Li
Susan Gould
Hualei Xin
Justin Cheung
1
+ PDF Chat Estimating actual SARS-CoV-2 infections from secondary data 2024 Wolfgang Rauch
Hannes Schenk
Nikolaus Rauch
Matthias Harders
Herbert Oberacher
Heribert Insam
Rudolf Markt
Norbert Kreuzinger
1
+ PDF Chat The real-time infection hospitalisation and fatality risk across the COVID-19 pandemic in England 2024 Thomas Ward
Martyn Fyles
Alex Glaser
Robert S. Paton
William Ferguson
Christopher E. Overton
1